science

Rovalpituzumab tesirine

Rovalpituzumab tesirine is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Rovalpituzumab tesirine rather than just read about it. In short: Rovalpituzumab tesirine (Rova-T) is an experimental antibody-drug conjugate targeting the protein DLL3 on tumor cells. It was originally developed by Stemcentrx and was purchased by AbbVie.

Key takeaways

Rovalpituzumab tesirine belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Rovalpituzumab tesirine to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Rovalpituzumab tesirine from memory before moving on to harder problems.

Reference excerpt

Rovalpituzumab tesirine (Rova-T) is an experimental antibody-drug conjugate targeting the protein DLL3 on tumor cells. It was originally developed by Stemcentrx and was purchased by AbbVie. It was tested for use in small-cell lung cancer, but development was terminated after unsuccessful phase III trial.

Development In 2018, an Independent Data Monitoring Committee found that in the TAHOE phase III trial, Rova-T shortened survival of lung cancer patients compared to SOC chemotherapy topotecan, prompting termination of trial enrollment. Another phase III trial (MERU) demonstrated no survival benefit over placebo. A phase II trial using the drug as a third-line treatment for relapsed or refractory lung cancer showed objective response rate at just 16%.

Chemical structure

Chemical structure of "tesirine" (drawn in black). It consists of a pyrrolobenzodiazepine type dimer (top), which is the actual anti-cancer agent, a Val–Ala structure that can be cleaved by an enzyme to detach the anti-cancer agent from the antibody, a polyethylene glycol spacer, and a maleimide linker which is attached to a cysteine in the antibody's (rovalpituzumab's) peptide backbone, drawn blue. Each rovalpituzumab molecule has an average of two such attachments.

See also Vadastuximab talirine, with a similar cytotoxin

References

Worked examples

Example 1 — a first encounter with Rovalpituzumab tesirine

Start with the simplest possible case. Write down what Rovalpituzumab tesirine claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Rovalpituzumab tesirine before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Rovalpituzumab tesirine ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Rovalpituzumab tesirine

In research: Rovalpituzumab tesirine appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Rovalpituzumab tesirine in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Rovalpituzumab tesirine is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antibody–drug conjugate, Drugs not assigned an ATC code, Experimental cancer drugs, so understanding it makes those chapters shorter.
In everyday life: Look for Rovalpituzumab tesirine outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Rovalpituzumab tesirine” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Rovalpituzumab tesirine in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Rovalpituzumab tesirine means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Rovalpituzumab tesirine out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Rovalpituzumab tesirine in simple terms?

Rovalpituzumab tesirine (Rova-T) is an experimental antibody-drug conjugate targeting the protein DLL3 on tumor cells. It was originally developed by Stemcentrx and was purchased by AbbVie.

Why does Rovalpituzumab tesirine matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Rovalpituzumab tesirine?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Rovalpituzumab tesirine.